Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaping Xu

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
Frontiers in Plant Science|May 19, 2022
The Genetic Architecture of Nitrogen Use Efficiency in Switchgrass (<i>Panicum virgatum</i> L.)Vivek Shrestha, Hari B Chhetri, David Kainer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2025
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)Lin Zhou, Jianguo Sun, Conghua Xie, et al.
Life Sciences|December 21, 2020
TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosisYulin Mo, Wenxiu Lai, Ying Zhong, et al.
Experimental Hematology & Oncology|March 15, 2024
Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasisLiang Liu, Xiaodong Chen, Leilei Wu, et al.
Chemical Science|September 11, 2025
Tailoring multi-dimensional hierarchical self-assembly of metallacages through balancing non-covalent interactionsXin Jiang, Yaping Xu, Haixin Zhang, et al.
Signal Transduction and Targeted Therapy|November 10, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trialShuo Yang, Xinyu Liu, Jia Yu, et al.
Journal of Medicinal Chemistry|July 12, 2024
Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical ScavengersYang Lu, Zexu Shen, Yaping Xu, et al.
Stem Cells and Development|August 19, 2024
Intrapericardial Administration of Human Pericardial Fluid Cells Improves Cardiac Functions in Rats with Heart FailureYaping Xu, Xiangli Zhang, Zhikun Fu, et al.
Frontiers in Immunology|September 9, 2020
<i>CCND1</i> Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid TumorsYu Chen, Yingying Huang, Xuan Gao, et al.
American Journal of Cancer Research|October 17, 2018
Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancerHuiping Li, Yaping Xu, Fangyuan Zhao, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
Frontiers in Plant Science|May 19, 2022
The Genetic Architecture of Nitrogen Use Efficiency in Switchgrass (<i>Panicum virgatum</i> L.)Vivek Shrestha, Hari B Chhetri, David Kainer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2025
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)Lin Zhou, Jianguo Sun, Conghua Xie, et al.
Life Sciences|December 21, 2020
TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosisYulin Mo, Wenxiu Lai, Ying Zhong, et al.
Experimental Hematology & Oncology|March 15, 2024
Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasisLiang Liu, Xiaodong Chen, Leilei Wu, et al.
Chemical Science|September 11, 2025
Tailoring multi-dimensional hierarchical self-assembly of metallacages through balancing non-covalent interactionsXin Jiang, Yaping Xu, Haixin Zhang, et al.
Signal Transduction and Targeted Therapy|November 10, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trialShuo Yang, Xinyu Liu, Jia Yu, et al.
Journal of Medicinal Chemistry|July 12, 2024
Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical ScavengersYang Lu, Zexu Shen, Yaping Xu, et al.
Stem Cells and Development|August 19, 2024
Intrapericardial Administration of Human Pericardial Fluid Cells Improves Cardiac Functions in Rats with Heart FailureYaping Xu, Xiangli Zhang, Zhikun Fu, et al.
Frontiers in Immunology|September 9, 2020
<i>CCND1</i> Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid TumorsYu Chen, Yingying Huang, Xuan Gao, et al.
American Journal of Cancer Research|October 17, 2018
Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancerHuiping Li, Yaping Xu, Fangyuan Zhao, et al.
Pageof 31